Buffalo Bills Fan Posted May 5, 2020 Share Posted May 5, 2020 I think people should Liberate Youtube. Taking down criticism WHO, and taking down videos on hydroxychloroquine. Sad that they do this kind of stuff.. 1 1 2 Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 Patent number: 9896509 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Grant Filed: August 3, 2016 Date of Patent: February 20, 2018 Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci 1 Link to comment Share on other sites More sharing options...
Kemp Posted May 5, 2020 Share Posted May 5, 2020 9 minutes ago, Reality Check said: Fine, take Trump's side if you must. You call the man a liar all the time but now you believe him. To each his own. By what definition is this not a pandemic? What was a real pandemic, or are you saying there is no such thing? Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 Publication number: 20160333097 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Application Filed: August 3, 2016 Publication date: November 17, 2016 Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Serv Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci 1 Link to comment Share on other sites More sharing options...
Kemp Posted May 5, 2020 Share Posted May 5, 2020 7 minutes ago, Cinga said: What I stated however, wasn't a feeling, it is an observable fact. ? Same as every other generation. Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 Patent number: 9441041 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Grant Filed: September 21, 2015 Date of Patent: September 13, 2016 Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci Publication number: 20160075786 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Application Filed: September 21, 2015 Publication date: March 17, 2016 Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Serv Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci Publication number: 20090285815 Abstract: Nucleic acids encoding recombinant CD4-fusion proteins are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C terminus of the heavy chain of an IgA antibody or a tailpiece from a C terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins. Type: Application Filed: March 21, 2008 Publication date: November 19, 2009 Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci Patent number: 7368114 Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion or the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody ara tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4 fusion proteins. Type: Grant Filed: October 24, 2002 Date of Patent: May 6, 2008 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci Publication number: 20040265306 Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody or a tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins. Type: Application Filed: July 27, 2004 Publication date: December 30, 2004 Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci 1 1 Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 Publication number: 20030180254 Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy. Type: Application Filed: January 23, 2003 Publication date: September 25, 2003 Applicant: The Govt. of the USA as represented by the Secretary of the Dept. of Health & Human Services Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci Patent number: 6548055 Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy. Type: Grant Filed: August 9, 2000 Date of Patent: April 15, 2003 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci Patent number: 6190656 Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy. Type: Grant Filed: September 2, 1997 Date of Patent: February 20, 2001 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci Patent number: 6190656 Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy. Type: Grant Filed: September 2, 1997 Date of Patent: February 20, 2001 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci Patent number: 5696079 Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy. Type: Grant Filed: May 26, 1995 Date of Patent: December 9, 1997 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci 1 Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 15 minutes ago, Reality Check said: How did the GP 120 which makes HIV so infectious, patented by Fauci, get into a bat virus? How much money will Fauci and his cronies make on causing and curing a "pandemic"? Do people even care any more? Link to comment Share on other sites More sharing options...
BuffaloHokie13 Posted May 5, 2020 Share Posted May 5, 2020 15 minutes ago, Kemp said: Do you really believe Fauci was blocked because he's too busy or was it a sarcastic remark? I don't know why, and I don't plan to assume. The point I was trying to make was that if Fauci is too busy to get additional information about Covid, he's definitely too busy for anything else non-Covid related - congress included. I think the point made sense within the context of the conversation, since @SectionC3 entertained it with an answer. 1 Link to comment Share on other sites More sharing options...
Boatdrinks Posted May 5, 2020 Share Posted May 5, 2020 28 minutes ago, Kemp said: When you behave like a cult by accepting everything that he says, true or not, it's hard to think of the group differently. Look; most who support Trump are able to think critically for themselves. Anyone who listens to him knows he goes off on tangents and his speaking style requires one to sift through his words. Personally, I don’t take everything he says as truth because it’s not logical to do so. That goes for anyone in politics. If he makes a statement such as the virus will go away, or there won’t be a second wave I dismiss it immediately. Why? Because he can’t possibly know this, and that is obvious ! It may be hopeful, and an attempt to prevent panic but it’s not a known fact. As for the pandemic, I think it is possible even likely there will be a second wave , and more. That’s how viruses work. As a society and a country we cannot afford the economic damage caused by closing everything down. It cannot be sustained by any nation because that’s not how economies work. Selling lockdowns as a route to being “ safe” is in short, a lie. We’re unlikely to be safer, but we do know more about the virus now. A vaccine may never happen, as we don’t have a vaccine for a known Coronavirus yet. Why pretend this virus is going away any time soon ? Why pretend no one else is going to die from it ? We have enough data now to know that the virus isn’t a very high risk to most people. We humans haven’t yet come up with a cure for death, and as a race we have a new cause of death on our hands. There are many others and we don’t sit inside and hide from them. We don’t destroy our economic foundation and reinvent our entire way of life because they exist. We don’t sacrifice our natural rights to government out of fear. Panic and fear are sold to the populace in order to take control of them. Link to comment Share on other sites More sharing options...
leh-nerd skin-erd Posted May 5, 2020 Share Posted May 5, 2020 13 minutes ago, SectionC3 said: To make an errant decision is not to make one undignified. You make a good point. The treason allegation is a terrible one, and it should be used only in the rarest of circumstances. To levy it wantonly is wrong and beneath the accuser and his/her office. https://www.axios.com/trump-treason-russia-investigation-new-york-times-e1660029-c73c-4809-8bd5-8988f1ed4fda.html Hmm. If you believed that the Benghazi video back story was accidentally created, I see your point. If you believe that the Russia investigation really just boiled down to a series of unfortunate events spanning a 4 year period, I can see your point. If you believe that the majority of American political candidates over the past few decades have spoke eloquently on the need to resolve the obvious issues at the southern border, only to errantly forget to address it over a 2, 4 or 8+ year term(s), I certainly follow you. But therein lies the rub--since we disagree on these fundamental issues, there can be no common ground to be found, and your definition of dignified behavior is largely irrelevant. The concept of dignity is a myth, though I would acknowledge that superficially, Joe Biden may have appeared Senatorial--and thus, on some level, dignified-- just prior to and immediately after sniffing hair/groping women/fishhooking staffers in back alleys. Of course, I don't know what you think the appropriate dignified response and demeanor of a sitting president should be to being accused of treason by the opposition party because you errantly missed that part of my reply. No worries though, I expected things would go this way, they generally do. Apologies to all for taking this off topic, I'm like one of the Four Wise Men, asking questions when people raise an issue, only to find that to certain questions there are no answers. Link to comment Share on other sites More sharing options...
SectionC3 Posted May 5, 2020 Share Posted May 5, 2020 26 minutes ago, BuffaloHokie13 said: Yeah, no idea on scope here either. My expectation is that the purpose was to fish for out of context soundbytes that sound contradictory to Trump to spread through the press, which would be a spectacular waste of time regardless of duration, but I readily admit that the thought is based on my personal bias. I didn’t read the whole thing (stumbled upon it looking for info on Amazon’s drop in the last hour). “Haters” is a ridiculous reason not to let the guy testify, especially if the Senate is worth his time. I still don’t know the scope or the point of the trip to the hill, but holy cow what a dumb reason to cite to prevent him from visiting the House. https://www.cnbc.com/2020/05/05/coronavirus-trump-blocked-anthony-fauci-house-testimony-because-of-haters.html 2 Link to comment Share on other sites More sharing options...
BuffaloHokie13 Posted May 5, 2020 Share Posted May 5, 2020 1 minute ago, SectionC3 said: I didn’t read the whole thing (stumbled upon it looking for info on Amazon’s drop in the last hour). “Haters” is a ridiculous reason not to let the guy testify, especially if the Senate is worth his time. I still don’t know the scope or the point of the trip to the hill, but holy cow what a dumb reason to cite to prevent him from visiting the House. https://www.cnbc.com/2020/05/05/coronavirus-trump-blocked-anthony-fauci-house-testimony-because-of-haters.html He is certainly a troll ?♂️ 1 Link to comment Share on other sites More sharing options...
SectionC3 Posted May 5, 2020 Share Posted May 5, 2020 2 minutes ago, leh-nerd skin-erd said: Hmm. If you believed that the Benghazi video back story was accidentally created, I see your point. If you believe that the Russia investigation really just boiled down to a series of unfortunate events spanning a 4 year period, I can see your point. If you believe that the majority of American political candidates over the past few decades have spoke eloquently on the need to resolve the obvious issues at the southern border, only to errantly forget to address it over a 2, 4 or 8+ year term(s), I certainly follow you. But therein lies the rub--since we disagree on these fundamental issues, there can be no common ground to be found, and your definition of dignified behavior is largely irrelevant. The concept of dignity is a myth, though I would acknowledge that superficially, Joe Biden may have appeared Senatorial--and thus, on some level, dignified-- just prior to and immediately after sniffing hair/groping women/fishhooking staffers in back alleys. Of course, I don't know what you think the appropriate dignified response and demeanor of a sitting president should be to being accused of treason by the opposition party because you errantly missed that part of my reply. No worries though, I expected things would go this way, they generally do. Apologies to all for taking this off topic, I'm like one of the Four Wise Men, asking questions when people raise an issue, only to find that to certain questions there are no answers. When you roll around with pigs you both get muddy. Trump is casual with the treason accusation, and the fact that somebody else might have been casual with it, too, doesn’t dignify his actions. Link to comment Share on other sites More sharing options...
Warren Zevon Posted May 5, 2020 Share Posted May 5, 2020 24 minutes ago, Reality Check said: MOAR! Already posted that one Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 24 minutes ago, Reality Check said: Patent number: 9896509 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Grant Filed: August 3, 2016 Date of Patent: February 20, 2018 Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci 2 minutes ago, Warren Zevon said: MOAR! Already posted that one Link to comment Share on other sites More sharing options...
SectionC3 Posted May 5, 2020 Share Posted May 5, 2020 2 minutes ago, BuffaloHokie13 said: He is certainly a troll ?♂️ Come on, if haters really is the reason why Fauci isn’t going to the House, don’t you think he could just slap on some hater blockers for protection and solve the problem? https://www.urbandictionary.com/define.php?term=haterblockers Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 23 minutes ago, Reality Check said: Patent number: 9441041 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Grant Filed: September 21, 2015 Date of Patent: September 13, 2016 Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci Publication number: 20160075786 Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV. Type: Application Filed: September 21, 2015 Publication date: March 17, 2016 Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Serv Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci Publication number: 20090285815 Abstract: Nucleic acids encoding recombinant CD4-fusion proteins are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C terminus of the heavy chain of an IgA antibody or a tailpiece from a C terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins. Type: Application Filed: March 21, 2008 Publication date: November 19, 2009 Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci Patent number: 7368114 Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion or the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody ara tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4 fusion proteins. Type: Grant Filed: October 24, 2002 Date of Patent: May 6, 2008 Assignee: The United States of America as represented by the Department of Health and Human Services Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci Publication number: 20040265306 Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody or a tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins. Type: Application Filed: July 27, 2004 Publication date: December 30, 2004 Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci 1 minute ago, SectionC3 said: Come on, if haters really is the reason why Fauci isn’t going to the House, don’t you think he could just slap on some hater blockers for protection and solve the problem? https://www.urbandictionary.com/define.php?term=haterblockers Link to comment Share on other sites More sharing options...
Buffalo_Gal Posted May 5, 2020 Share Posted May 5, 2020 1 hour ago, plenzmd1 said: I have zero issue wearing a mask, and have been doing so since prolly late March...logically i know Bills games with full stadiums gunna be tough lift..emotionally i am ever optimistic with all the AI and the whole world working os medical solution we will get something in June or July that lets normal activities return by September If you want to wear a mask, find an N95 one. This study on the NCBI part of the NIH site showing N95 masks are great (which we have all heard). Any other type of mask? Ummm ... </snip>Laboratory tests showed the penetration of particles through the cloth masks to be very high (97%) compared with medical masks (44%) (used in trial) and 3M 9320 N95 (<0.01%), 3M Vflex 9105 N95 (0.1%). </snip> Link to comment Share on other sites More sharing options...
Reality Check Posted May 5, 2020 Share Posted May 5, 2020 In 2019, with the backing of NIAID, the National Institutes of Health committed $3.7 million over six years for research that included some gain-of-function work. The program followed another $3.7 million, 5-year project for collecting and studying bat coronaviruses, which ended in 2019, bringing the total to $7.4 million. Many scientists have criticized gain of function research, which involves manipulating viruses in the lab to explore their potential for infecting humans, because it creates a risk of starting a pandemic from accidental release. Ads by scrollerads.com SARS-CoV-2 , the virus now causing a global pandemic, is believed to have originated in bats. U.S. intelligence, after originally asserting that the coronavirus had occurred naturally, conceded last month that the pandemic may have originated in a leak from the Wuhan lab. (At this point most scientists say it's possible—but not likely—that the pandemic virus was engineered or manipulated.) Dr. Fauci did not respond to Newsweek's requests for comment. NIH responded with a statement that said in part: "Most emerging human viruses come from wildlife, and these represent a significant threat to public health and biosecurity in the US and globally, as demonstrated by the SARS epidemic of 2002-03, and the current COVID-19 pandemic.... scientific research indicates that there is no evidence that suggests the virus was created in a laboratory." Link to comment Share on other sites More sharing options...
Recommended Posts